By Stephen Nakrosis Shares of Alpine Immune Sciences were trading sharply higher in Wednesday s after-hours market, following news Vertex Pharmaceuticals agreed to acquire the company in a.
Alpine Immune Sciences (NASDAQ:ALPN) Given New $50 00 Price Target at HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.